Project description and Aims
The ASK (Action Success Knowledge) clinical trial is an NHMRC-funded cluster randomised control trial.
The overarching aim of the ASK study is to decrease the incidence of depressive symptoms for people with aphasia and their caregivers. The specific aims are to determine whether a tailored, early intervention program (Aphasia ASK) leads to better mood and overall quality of life outcomes than an attention control (a secondary stroke prevention intervention) at 12 months post-stroke in both patients with aphasia and their caregivers.
Design and method
Twenty metro and non-metro health networks across Australia will administer an experimental or an attention control intervention to individuals with aphasia and their family members.
The ASK trial is currently running in speech pathology services in:
- New South Wales
- Western Australia
- Australian Capital Territory.
The study aims to recruit 440 individuals with aphasia across the country between now and the end of 2018. Analysis and publications will be available from 2018.
Expected date of completion